Joinn Laboratories (China) Co (SHSE:603127) EV-to-Revenue : 3.59 (As of May. 23, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Joinn Laboratories (China) Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Joinn Laboratories (China) Co's enterprise value is ¥8,365 Mil. Joinn Laboratories (China) Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2,332 Mil. Therefore, Joinn Laboratories (China) Co's EV-to-Revenue for today is 3.59.

The historical rank and industry rank for Joinn Laboratories (China) Co's EV-to-Revenue or its related term are showing as below:

SHSE:603127' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.54 Med: 17.24 Max: 51.73
Current: 3.4

During the past 12 years, the highest EV-to-Revenue of Joinn Laboratories (China) Co was 51.73. The lowest was 3.54. And the median was 17.24.

SHSE:603127's EV-to-Revenue is ranked worse than
51.8% of 222 companies
in the Medical Diagnostics & Research industry
Industry Median: 3.29 vs SHSE:603127: 3.40

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-05-23), Joinn Laboratories (China) Co's stock price is ¥16.22. Joinn Laboratories (China) Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥3.44. Therefore, Joinn Laboratories (China) Co's PS Ratio for today is 4.71.

Joinn Laboratories (China) Co EV-to-Revenue Historical Data

The historical data trend for Joinn Laboratories (China) Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Joinn Laboratories (China) Co EV-to-Revenue Chart

Joinn Laboratories (China) Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

14.17

21.37

25.90

12.37

6.15

Joinn Laboratories (China) Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EV-to-Revenue	Get a 7-Day Free Trial															10.54	7.09	5.74	6.15	4.42

Competitive Comparison of Joinn Laboratories (China) Co's EV-to-Revenue

For the Diagnostics & Research subindustry, Joinn Laboratories (China) Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Joinn Laboratories (China) Co's EV-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Joinn Laboratories (China) Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Joinn Laboratories (China) Co's EV-to-Revenue falls into.

Joinn Laboratories (China) Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Joinn Laboratories (China) Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	8364.671	/	2331.909
	=	3.59

Joinn Laboratories (China) Co's current Enterprise Value is ¥8,365 Mil.
Joinn Laboratories (China) Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥2,332 Mil.

Joinn Laboratories (China) Co (SHSE:603127) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Joinn Laboratories (China) Co's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	16.22	/	3.443
	=	4.71

Joinn Laboratories (China) Co's share price for today is ¥16.22.
Joinn Laboratories (China) Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥3.44.

Joinn Laboratories (China) Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Joinn Laboratories (China) Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Joinn Laboratories (China) Co (SHSE:603127) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Joinn Laboratories (China) Co Ltd (SHSE:603127) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

06127:Hong Kong

Address

A5 Rongjing East Street, Beijing Economic-Technological Development Area, Beijing, CHN, 100176

Website

https://www.joinnlabs.com

Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non- Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.

Joinn Laboratories (China) Co (SHSE:603127) Headlines

No Headlines